Insider Trading February 9, 2026

PayPal EVP Sells $139,815 in Stock as Branded Checkout Growth Slows and Analysts Cut Targets

Frank Keller executed a Rule 10b5-1 sale; multiple brokerages have trimmed price targets amid weaker Branded Checkout metrics

By Maya Rios PYPL
PayPal EVP Sells $139,815 in Stock as Branded Checkout Growth Slows and Analysts Cut Targets
PYPL

Frank Keller, executive vice president at PayPal, disposed of 3,478 shares on February 6, 2026, under a pre-arranged 10b5-1 plan. The transaction and broader company performance coincide with a slowdown in Branded Checkout growth and a wave of analyst downgrades and price-target reductions reflecting concerns about transaction margins and execution.

Key Points

  • Frank Keller sold 3,478 PayPal shares on February 6, 2026, at $40.20 per share, totaling $139,815; he now directly holds 51,567 shares.
  • Sale executed under a Rule 10b5-1 trading plan adopted October 30, 2025.
  • Multiple brokerages cut price targets or downgraded PayPal following a 1% year-over-year increase in Branded Checkout, with concerns about declining transaction margin dollars in Q1 and throughout 2026 - impacts sectors including fintech, payments, and e-commerce.

Frank Keller, an executive vice president at PayPal (NASDAQ:PYPL), sold 3,478 shares of the company's common stock on February 6, 2026, at $40.20 per share. The transaction totaled $139,815, according to a Form 4 filed with the Securities and Exchange Commission. Following the sale, Keller's direct ownership in PayPal stands at 51,567 shares.

The filing notes the sale was carried out under a pre-established Rule 10b5-1 trading plan adopted on October 30, 2025, indicating the transaction was scheduled in advance rather than executed opportunistically.


Separately, PayPal has faced a series of operational and market-performance headwinds that have prompted several brokerages to revise their outlooks. The company reported Branded Checkout growth of only 1% year-over-year, a deceleration that management and analysts expect will translate into lower transaction margin dollars in the first quarter and across 2026.

That slowdown has led to multiple changes in broker recommendations and price targets:

  • RBC Capital lowered its price target to $59.00, citing an abrupt CEO change and tepid growth in Branded Checkout total payment volume.
  • Wells Fargo reduced its target to $48.00, attributing the move to execution-related concerns after PayPal missed earnings and revised guidance.
  • HSBC downgraded the stock from Buy to Hold and cut its price target to $47.00, pointing to worries about losses in e-commerce market share.
  • Canaccord Genuity shifted to a Hold rating and sharply lowered its price target to $42.00, even as it acknowledged the company’s strong cash flow.
  • Citizens downgraded PayPal from Market Outperform to Market Perform, citing the slowdown in Branded Checkout volumes and anticipated declines in transaction margins.

The combination of an insider sale executed under a planned trading program and a cluster of analyst downgrades underscores heightened scrutiny of PayPal's near-term growth trajectory and margin profile. Market participants will be watching upcoming results and guidance for confirmation that branded checkout volumes and transaction margins stabilize.

Risks

  • Slower Branded Checkout growth and an expected decline in transaction margin dollars could pressure PayPal's revenue and margins - affecting the fintech and payments sectors.
  • An abrupt CEO change noted by at least one brokerage increases execution uncertainty for the company and may influence investor confidence - relevant to corporate governance and market sentiment in financial services.
  • Analyst downgrades and lowered price targets may weigh on the stock's near-term performance and could amplify volatility in the payment-processing and e-commerce-related equities.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026